IP Library › Granted Patent US 11,540,507
Granted Patent B2
US 11,540,507 · App. 16/344,798 · Granted Jan 3, 2023

Solution for cryopreservation of animal cells or animal tissues, cryopreserved product, and cryopreservation method

Inventors: Tokiko Nagamura (Tokyo, JP); Yuka Mori (Tokyo, JP); Takahisa Shimadzu (Tokyo, JP)
Assignee: The University of Tokyo
A01N1/0221C12N1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,540,507
App. No.
16/344,798
Granted
Jan 3, 2023
Kind
B2
Abstract

The present invention provides a solution for cryopreservation of animal cells or animal tissues which substantially includes a cryoprotectant that contains 0.5 w/v % to 6.0 w/v % of dextran or derivatives thereof or salts thereof and contains dimethyl sulfoxide, and includes a physiological aqueous solution; a cryopreserved product of animal cells or animal tissues which includes animal cells or animal tissues, and includes the above-described solution for cryopreservation of animal cells or animal tissues; and a cryopreservation method of animal cells or animal tissues, which is a method using the above-described solution for cryopreservation of animal cells or animal tissues.

Claims (12)

1. A cryopreserved product of mesenchymal cells or mesenchymal stem cells, comprising:

mesenchymal cells or mesenchymal stem cells; and

a solution for cryopreservation of mesenchymal cells or mesenchymal stem cells which substantially comprises a cryoprotectant that contains 3.0 w/v % to 4.5 w/v % of dextran or derivatives thereof or salts thereof, and dimethyl sulfoxide, and a physiological aqueous solution, and does not comprise serum.

2. The cryopreserved product of mesenchymal cells or mesenchymal stem cells according to claim 1 , wherein the mesenchymal cells or mesenchymal stem cells are derived from an umbilical cord or umbilical cord blood.

3. A cryopreservation method of mesenchymal cells or mesenchymal stem cells, comprising:

immersing mesenchymal cells or mesenchymal stem cells in a solution for cryopreservation of mesenchymal cells or mesenchymal stem cells; and

freezing the mesenchymal cells or mesenchymal stem cells while in an immersed state in the solution for cryopreservation,

wherein the solution substantially comprises a cryoprotectant that contains 3.0 w/v % to 4.5 w/v % of dextran or derivatives thereof or salts thereof, and dimethyl sulfoxide, and a physiological aqueous solution, and does not comprise serum.

4. The cryopreserved product of mesenchymal cells or mesenchymal stem cells according to claim 1 , wherein the amount of dimethyl sulfoxide is 1.0 v/v % to 15.0 v/v %.

5. The cryopreserved product of mesenchymal cells or mesenchymal stem cells according to claim 1 , wherein the solution further comprises citric acid or hydrates thereof or salts thereof, and a pH of the solution is 6.0 to 8.0.

6. The cryopreserved product of mesenchymal cells or mesenchymal stem cells according to claim 1 , wherein the solution further comprises glucose.

7. The cryopreserved product of mesenchymal cells or mesenchymal stem cells according to claim 1 , wherein the physiological aqueous solution comprises magnesium, potassium, calcium, sodium, and bicarbonate ions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2019
From: NAGAMURA, TOKIKO; MORI, YUKA; SHIMADZU, TAKAHISA
To: THE UNIVERSITY OF TOKYO
Reel/Frame 050184/0179 →
Priority Claims (1)
JP JP2016-216346 · Nov 4, 2016 · national
Continuity (1)
Related Publication 20210169069A1 · Jun 10, 2021